Mechanisms of quinolone action and microbial response

被引:188
作者
Hawkey, PM
机构
[1] Birmingham Heartlands Hosp, Publ Hlth Lab, Birmingham B5 9SS, W Midlands, England
[2] Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England
关键词
antibiotic action; antibiotic resistance; fluoroquinolones;
D O I
10.1093/jac/dkg207
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Over the years, chromosomal mapping of the bacterial genome of Escherichia coli has demonstrated that many loci are associated with quinolone resistance, which is mainly a result of chromosomal mutation or alteration of the quantity or type of porins in the outer membrane of Gram-negative bacteria. There has been one report of a small and confined episode of plasmid-mediated resistance to fluoroquinolones, which did not appear to persist. With the increasingly widespread use of an expanding range of fluoroquinolone antibiotics, a range and mix in individual bacterial isolates of the different mechanisms of resistance to fluoroquinolones will undoubtedly be encountered amongst clinically significant bacteria. Currently, transferable resistance is extremely rare and most resistant bacteria arise from clonal expansion of mutated strains. However, it is conceivable that in the future, horizontal gene transfer may become a more important means of conferring resistance to fluoroquinolones.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 43 条
  • [1] Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995
    Brueggemann, AB
    Coffman, SL
    Rhomberg, P
    Huynh, H
    Almer, L
    Nilius, A
    Flamm, R
    Doern, GV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 680 - 688
  • [2] DNA gyrase and topoisomerase IV on the bacterial chromosome: Quinolone-induced DNA cleavage
    Chen, CR
    Malik, M
    Snyder, M
    Drlica, K
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 258 (04) : 627 - 637
  • [3] Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000
    Critchley, IA
    Blosser-Middleton, RS
    Jones, ME
    Karlowsky, JA
    Karginova, EA
    Thornsberry, C
    Sahm, DF
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (02) : 100 - 107
  • [4] Comparative in vitro and in vivo activity of the c-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118
    Dalhoff, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 : S16 - S21
  • [5] Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance
    Dong, YZ
    Xu, C
    Zhao, XL
    Domagala, J
    Drlica, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2978 - 2984
  • [6] DNA gyrase, topoisomerase IV, and the 4-quinolones
    Drlica, K
    Zhao, XL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) : 377 - +
  • [7] Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae
    Gill, MJ
    Brenwald, NP
    Wise, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 187 - 189
  • [8] Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone
    Ho, PL
    Yam, WC
    Cheung, TKM
    Ng, WWS
    Que, TL
    Tsang, DNC
    Ng, TK
    Seto, WH
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (05) : 906 - 908
  • [9] COMPARISON OF INHIBITION OF ESCHERICHIA-COLI TOPOISOMERASE-IV BY QUINOLONES WITH DNA GYRASE INHIBITION
    HOSHINO, K
    KITAMURA, A
    MORRISSEY, I
    SATO, K
    KATO, J
    IKEDA, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) : 2623 - 2627
  • [10] JACOBY GA, 2001, 41 INT C ANT AG CHEM, P145